Home » Newsletters » BioWorld Science

BioWorld Science

June 23, 2014

View Archived Issues

BIND Therapeutics partners with Roche on targeted nanopharmaceuticals

Vernalis and Servier Bcl-2 inhibitor enters phase I

German group synthesizes novel protein kinase inhibitors for cancer

New agents for hepatitis C virus presented by HEC Pharm

ChemoCentryx designs new chemokine receptor ligands

Enanta Pharmaceuticals designs new cyclosporin analogues for HCV and HIV infection

German researchers patent novel agents for pain and other disorders

Researchers at Roche design novel Hdm2 inhibitors for cancer

Antibe Therapeutics receives Canadian clearance to begin phase I program for ATB-346

Kadmon advances study of KD-020 in autosomal dominant polycystic kidney disease

Navitor Pharmaceuticals established to identify mTORC1 pathway drugs

Updated phase I/II data on AP-26113 in NSCLC reported

Novel candidate PET ligands for central histamine H3 receptors

Sanofi to return rights to MM-121 to Merrimack

Alnylam and the Alpha-1 Project form collaboration for ALN-AAT

GlycoMimetics begins phase I trial of GMI-1271 as a potential drug for blood-related cancers

Apitope begins preclinical Graves' disease program

International Stem Cell completes study in Parkinson's disease program

Molecular probe developed for optical imaging of Bcl-2 expression during chemotherapy

Mesenchymal stromal cell therapy evaluated in idiopathic osteonecrosis of femoral head

Safety and efficacy of autologous progenitor cells in pediatric hypoplastic left heart syndrome

Enrollment completed in phase II studies of VB-201 in psoriasis and ulcerative colitis

SillaJen changes name following acquisition of Jennerex

Arrowhead unveils RNAi candidate for alpha-1-antitrypsin-associated liver disease

FDA approves oral and intravenous tedizolid phosphate for bacterial skin infections

Japanese approval of Prevenar 13 expanded to include elderly people

Mirena 52 mg approved for additional indication in Japan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...